Edap TMS SA ADR FOCL

Morningstar Rating
$4.09 −0.04 (0.97%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FOCL is trading at a LOCK|$>V!Tt premium.
Price
$4.14
Fair Value
LOCK|yv^&$#W
Uncertainty
LOCK|cDV
1-Star Price
LOCK|bw#@SkL
5-Star Price
LOCK|^dJWn&M
Economic Moat
LOCK|X<
Capital Allocation
—

Trading Information

Previous Close Price
$4.13
Day Range
$3.97–4.30
52-Week Range
$1.75–6.40
Bid/Ask
$4.06 / $4.12
Shares Outstanding
47.22M
Market Cap
$193.12M
Volume/Avg
85,071 / 112,892

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
1.68
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Small Value
Total Number of Employees
289

Valuation

Metric
FOCL
Price/Earnings (Normalized)
—
Price/Book Value
—
Price/Sales
1.68
Price/Cash Flow
—
Price/Earnings
FOCL

Financial Strength

Metric
FOCL
Quick Ratio
0.88
Current Ratio
1.60
Interest Coverage
−5.11
Quick Ratio
FOCL

Profitability

Metric
FOCL
Return on Assets (Normalized)
−69.62%
Return on Equity (Normalized)
−304.91%
Return on Invested Capital (Normalized)
−113.94%
Return on Assets
FOCL

Medical Distribution Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
McKesson Corp
MCK
LOCK|P^V?F><LOCK|V!nXw$117B
Cencora Inc
COR
LOCK|XL$$WxBLOCK|!&!R$65B
Cardinal Health Inc
CAH
LOCK|@sGFc%>LOCK|&tT>$59B
Sigma Healthcare Ltd
SIGGF
—LOCK|fwVD$23B
Henry Schein Inc
HSIC
LOCK|%Z%W^&LOCK|rfDg$10B
Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
—LOCK|?!f$8B
Sinopharm Group Co Ltd ADR
SHTDY
—LOCK|<@$6B
Sinopharm Group Co Ltd
SHTDF
—LOCK|!c$6B
Galenica Ltd
GALNF
—LOCK|!Vp!$5B
Medipal Holdings Corp
MEPDF
—LOCK|r^$4B

Sponsor Center